1 asset in Hyperparathyroidism
Therapeutic assets addressing Hyperparathyroidism, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Vitamin D Hyperparathyroidism | Taipei Medical University Hospital | P2 | B (57) |
Therapeutic assets addressing Hyperparathyroidism, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Vitamin D Hyperparathyroidism | Taipei Medical University Hospital | P2 | B (57) |